Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature

Hanne Sommerfelt¹, Lene F Sandvik^{2

3}, Ingeborg M Bachmann^{2

3}, Ragnvald Ljones Brekke⁴, Henrik Løvendahl Svendsen⁴, Anne Berit Guttormsen^{3

5}, Sura Aziz⁶, Hanna Dillekås¹, Oddbjørn Straume^{1

7

8}

Affiliations

¹ Department of Oncology, Haukeland University Hospital, Bergen, Norway.
² Department of Dermatology, Haukeland University Hospital, Bergen, Norway.
³ Department of Clinical Medicine, University of Bergen, Bergen, Norway.
⁴ Department of Plastic, Hand, and Reconstructive surgery, National Burn Centre, Haukeland University Hospital, Bergen, Norway.
⁵ Department of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.
⁶ Department of Pathology, Haukeland University Hospital Bergen, Bergen, Norway.
⁷ Department of Clinical Science, University of Bergen, Bergen, Norway.
⁸ Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.

Review

Hanne Sommerfelt et al. Acta Oncol. 2022 Oct.

. 2022 Oct;61(10):1295-1299.

doi: 10.1080/0284186X.2022.2119099. Epub 2022 Sep 8.

¹ Department of Oncology, Haukeland University Hospital, Bergen, Norway.
² Department of Dermatology, Haukeland University Hospital, Bergen, Norway.
³ Department of Clinical Medicine, University of Bergen, Bergen, Norway.
⁴ Department of Plastic, Hand, and Reconstructive surgery, National Burn Centre, Haukeland University Hospital, Bergen, Norway.
⁵ Department of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.
⁶ Department of Pathology, Haukeland University Hospital Bergen, Bergen, Norway.
⁷ Department of Clinical Science, University of Bergen, Bergen, Norway.
⁸ Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.

No abstract available

Publication types